Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
002932.SZ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.31B
Close$
$1.35
90.7% downside
Current Fair Value
90.7% downsideOvervalued by 90.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.31 Billion |
|---|---|
| Enterprise Value | $2.98 Billion |
| Earnings per Share | $-0.07 |
| Beta | 0.35 |
| Outstanding Shares | 210,049,264 |
Return
| Return on Equity | -0.95% |
|---|---|
| Return on Assets | -0.88% |
| Return on Invested Capital | -1.77% |
Valuation & Multiples
| P/E Ratio | -65.38 |
|---|---|
| PEG | 28.06 |
| Price to Sales | 14.51 |
| Price to Book Ratio | 0.56 |
| Enterprise Value to Revenue | 11.17 |
| Enterprise Value to EBIT | -30.46 |
| Enterprise Value to Net Income | -59 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 2, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
April 23, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
599 employees
CEO: Chen Li Li
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. specializes in the research, development, manufacturing, and global distribution of in vitro diagnostic (IVD) reagents and related equipment. Their extensive product line features molecular diagn...